A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT02236013 · COMPLETED
Trial details
- NCT number
- NCT02236013
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-07
- Primary completion
- 2021-07-26
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.